Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial. - Rossing,K.; Jacobsen,P.; Pietraszek,L.; Parving,H.H. (Diabetes Care, 2003)